Enrichment of a CD4-CD8- NK-like cytotoxic Vδ1/3 T cell subset in tuberculosis disease
Tuberculosis (TB), caused by Mycobacterium tuberculosis, remains a leading cause of global morbidity and mortality. Although gamma-delta ({gamma}{delta}) T cells have increasingly been suggested to contribute to the TB immune response, quantitative and qualitative differences in this immune cell compartment between healthy and TB diseased individuals are not well-characterized. In this study, we used single-cell RNA sequencing to provide a high-resolution characterization of CD4-CD8- {gamma}{delta} T cells in peripheral blood across healthy Mtb-non-sensitized, healthy Mtb-sensitized, and TB disease pre-/post-treatment cohorts. We found upregulation of an activated and cytotoxic gene signature in {gamma}{delta} T cells of TB disease compared to both healthy cohorts. Strikingly, these differences persisted through one year following diagnosis of TB disease (corresponding to six months after completion of anti-TB therapy). We found that these transcriptomic differences were largely mediated by an NK-like cytotoxic V{delta}1 and V{delta}3 subset that was enriched in TB disease, with a unique V{delta}3 TCR gene usage. Our findings suggest long-lasting changes in the CD4-CD8- {gamma}{delta} T cell compartment and highlight V{delta}3 cells, a previously underappreciated {gamma}{delta} T cell subset, as potentially important in TB.